A detailed history of Lgt Group Foundation transactions in Haleon PLC stock. As of the latest transaction made, Lgt Group Foundation holds 17,972 shares of HLN stock, worth $164,803. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,972
Previous 14,535 23.65%
Holding current value
$164,803
Previous $149,000 24.83%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 22, 2025

BUY
$9.27 - $11.41 $31,860 - $39,216
3,437 Added 23.65%
17,972 $186,000
Q1 2025

May 13, 2025

SELL
$9.02 - $10.67 $145,907 - $172,597
-16,176 Reduced 52.67%
14,535 $149,000
Q4 2024

Feb 06, 2025

BUY
$9.23 - $10.71 $283,462 - $328,914
30,711 New
30,711 $293,000
Q2 2023

Jul 27, 2023

BUY
$8.04 - $9.0 $91,012 - $101,880
11,320 New
11,320 $94,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $42.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.